Literature DB >> 950592

Pharmacokinetics of isoniazid metabolism in man.

G A Ellard, P T Gammon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 950592     DOI： 10.1007/bf01086149

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  29 in total

1.  A study of the renal clearances, metabolic inactivation rates, and serum fall-off interaction of isoniazid and paraminosalicylic acid in man.

Authors:  J W JENNE; F M MACDONALD; E MENDOZA
Journal:  Am Rev Respir Dis       Date:  1961-09

2.  The influence of bacterial gut hydrolysis on the fate of orally administered isonicotinuric acid in man.

Authors:  H G Boxenbaum; G S Jodhka; A C Ferguson; S Riegelman; T R MacGregor
Journal:  J Pharmacokinet Biopharm       Date:  1974-06

3.  General considerations in the choice and management of regimens of chemotherapy for pulmonary tuberculosis.

Authors:  W Fox
Journal:  Bull Int Union Tuberc       Date:  1972-02

4.  Pharmacokinetic studies with an isoniazid slow-releasing matrix preparation.

Authors:  L Eidus; M M Hodgkin; A H Hsu; O Schaefer
Journal:  Am Rev Respir Dis       Date:  1974-07

5.  The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine.

Authors:  A Víznerová; Z Slavíková; G A Ellard
Journal:  Tubercle       Date:  1973-03

6.  The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.

Authors:  G A Ellard; P T Gammon; S M Wallace
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

7.  A study of the availability of six commercial formulations of isoniazid.

Authors:  R Gelber; P Jacobsen; L Levy
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

8.  Comparative studies on the metabolism of isoniazid and isoniazid hydroazones in the dog.

Authors:  J H Peters; V E Hayes
Journal:  Arch Int Pharmacodyn Ther       Date:  1966-02

9.  Kinetic considerations relating to the accrual and elimination of drug metabolites.

Authors:  A J Cummings; B K Martin; G S Park
Journal:  Br J Pharmacol Chemother       Date:  1967-02

Review 10.  Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis.

Authors:  G A Ellard
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875
View more
  49 in total

1.  Liver and pancreatic injury induced by antituberculous therapy.

Authors:  M Markov; K Patel; A Raeesy; A Bant; D H Van Thiel; A Nadir
Journal:  Dig Dis Sci       Date:  2007-02-15       Impact factor: 3.199

2.  Pharmacokinetics of isoniazid and some metabolites in man.

Authors:  H G Boxenbaum; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

3.  Effect of efavirenz-based antiretroviral therapy and high-dose rifampicin on the pharmacokinetics of isoniazid and acetyl-isoniazid.

Authors:  Maxwell T Chirehwa; Helen McIlleron; Lubbe Wiesner; Dissou Affolabi; Oumou Bah-Sow; Corinne Merle; Paolo Denti
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

4.  Increased urinary excretion of toxic hydrazino metabolites of isoniazid by slow acetylators. Effect of a slow-release preparation of isoniazid.

Authors:  E Peretti; G Karlaganis; B H Lauterburg
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Pharmacokinetics of isoniazid: influence of age.

Authors:  M F Kergueris; M Bourin; C Larousse
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 6.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

7.  A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct.

Authors:  Sebabrata Mahapatra; Lisa K Woolhiser; Anne J Lenaerts; John L Johnson; Kathleen D Eisenach; Moses L Joloba; W Henry Boom; John T Belisle
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

8.  Effect of prednisolone and rifampin on isoniazid metabolism in slow and rapid inactivators of isoniazid.

Authors:  G R Sarma; S Kailasam; N G Nair; A S Narayana; S P Tripathy
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

9.  An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs.

Authors:  G A Ellard; P J Jenner; P A Downs
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

10.  [Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)].

Authors:  E Musch; M Eichelbaum; J K Wang; W von Sassen; M Castro-Parra; H J Dengler
Journal:  Klin Wochenschr       Date:  1982-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.